<code id='634D688587'></code><style id='634D688587'></style>
    • <acronym id='634D688587'></acronym>
      <center id='634D688587'><center id='634D688587'><tfoot id='634D688587'></tfoot></center><abbr id='634D688587'><dir id='634D688587'><tfoot id='634D688587'></tfoot><noframes id='634D688587'>

    • <optgroup id='634D688587'><strike id='634D688587'><sup id='634D688587'></sup></strike><code id='634D688587'></code></optgroup>
        1. <b id='634D688587'><label id='634D688587'><select id='634D688587'><dt id='634D688587'><span id='634D688587'></span></dt></select></label></b><u id='634D688587'></u>
          <i id='634D688587'><strike id='634D688587'><tt id='634D688587'><pre id='634D688587'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          fashion

          author:hotspot    - browse:24
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge